• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - surgery - Page 4
Tag:

surgery

Health

Late-night eating may amplify the effects of stress on gut health

by Chief Editor April 23, 2026
written by Chief Editor

The Convergence of Stress and Timing: A Recent Era of Gut Health

For years, we have understood that chronic stress is a primary trigger for bowel dysfunction, often manifesting as sudden bouts of diarrhea or frustrating constipation. However, emerging research presented at Digestive Disease Week (DDW) 2026 suggests that the clock may be just as important as the stressor.

View this post on Instagram about Recent, Health
From Instagram — related to Recent, Health

The conversation is shifting from simply what we eat to when we eat. This intersection of timing and tension is creating a “double hit” to our digestive systems, potentially accelerating the decline of gut health in an increasingly high-pressure world.

Did you know? Researchers apply a metric called “allostatic load” to measure cumulative physiological stress. This score considers factors like blood pressure, cholesterol levels, and body mass index (BMI) to determine how much wear and tear stress has placed on the body.

Understanding the ‘Double Hit’ Phenomenon

Recent data highlights a concerning synergy between late-night eating and chronic stress. When the body is already under significant physiological strain, the timing of caloric intake can amplify digestive issues.

Analysis of over 11,000 participants in the National Health and Nutrition Examination Survey revealed a stark trend: individuals with a high allostatic load who consumed more than 25% of their daily calories after 9 p.m. Were 1.7 times more likely to suffer from constipation and diarrhea compared to low-stress individuals who avoided late-night eating.

The Microbiome Connection

The impact extends beyond simple bowel movements. Data from more than 4,000 participants in the American Gut Project indicates that those combining high stress with late-night eating habits were 2.5 times more likely to report bowel problems.

Crucially, these individuals exhibited significantly lower gut microbiome diversity. This suggests that the timing of our meals may magnify the negative impact of stress on our internal bacteria via the gut-brain axis—the complex communication network of hormones, nerves, and bacteria that links our mind and our gut.

Pro Tip: To support your digestive function, try establishing a structured meal routine. Shifting your larger meals to earlier in the day can help align your eating patterns with your body’s natural rhythms.

The Future of Chrononutrition

We are entering the age of “chrononutrition,” the study of how our body’s circadian rhythms influence the way we process food. As we look forward, the focus of digestive wellness is likely to move toward personalized timing schedules.

The REAL Dangers of Late-Night Eating And How It Affects Your Health

Rather than generic dietary advice, future trends suggest a move toward managing the gut-brain axis by aligning nutrient intake with physiological stress levels. By reducing the “double hit” of late-night calories and high stress, individuals may be able to protect their microbiome diversity and improve overall bowel regularity.

As Dr. Harika Dadigiri, a resident physician at New York Medical College, notes, the goal isn’t to eliminate treats entirely, but to be mindful of timing. Small, consistent shifts in when we eat can lead to long-term improvements in how our bodies handle stress.

For more insights on maintaining a healthy system, explore our guides on optimizing gut health and managing stress-related wellness.

Frequently Asked Questions

Does eating late at night always cause bowel problems?
Not necessarily. The research suggests that late-night eating (more than 25% of calories after 9 p.m.) specifically amplifies digestive issues when combined with high levels of chronic stress.

Frequently Asked Questions
Health Recent

What is the gut-brain axis?
It’s a two-way communication system involving nerves, hormones, and gut bacteria that allows the brain and the gastrointestinal system to influence one another.

How does stress affect the gut microbiome?
High stress, especially when paired with poor meal timing, is associated with lower gut microbiome diversity, which can lead to an increase in bowel dysfunction.

Join the Conversation

Do you find your digestion changes during high-stress periods? Have you noticed a difference in how you feel when you eat later in the evening?

Share your experiences in the comments below or subscribe to our newsletter for the latest updates in digestive health science!

April 23, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Minimally invasive PTAB shows promise for patients with complex peripheral arterial disease

by Chief Editor April 23, 2026
written by Chief Editor

The Evolution of PAD Treatment: Moving Beyond Traditional Leg Bypass

For millions of people living with peripheral arterial disease (PAD), the prospect of restoring blood flow to the legs has historically meant a difficult choice: minimally invasive endovascular therapies that may not be sufficient for complex blockages, or high-risk open surgical bypass surgery.

However, a shift is occurring in the landscape of vascular care. The emergence of Percutaneous Transmural Arterial Bypass (PTAB) is redefining how clinicians approach long-segment superficial femoral artery (SFA) and popliteal artery occlusions, offering a middle ground that combines the logic of a surgical bypass with the recovery profile of a minimally invasive procedure.

Did you know? PAD is a global health challenge impacting over 200 million people worldwide. Without effective treatment, reduced blood flow can lead to severe complications, including the risk of limb loss.

Breaking the ‘Runoff’ Barrier in Complex PAD

One of the most significant hurdles in treating advanced PAD has been “distal runoff”—the number of arteries that successfully carry blood to the lower leg, and foot. Traditionally, patients with single-vessel runoff (where only one of the three main arteries is functional) were viewed as high-risk, often leaving them with limited options other than open surgery.

Recent data from the RODEO-PTAB substudy of the DETOUR2 trial has challenged this paradigm. By analyzing three-year data, researchers evaluated whether having only one runoff vessel predicted poorer outcomes after PTAB using the DETOUR System from Endologix LLC.

The Data: Single-Vessel vs. Multi-Vessel Outcomes

The findings suggest that the number of runoff vessels does not significantly hinder the success of PTAB. In a study of 191 evaluable patients, the results were strikingly similar across both groups:

View this post on Instagram about System, Bypass
From Instagram — related to System, Bypass
  • Primary Patency: At three years, patency was 52.1% for single-vessel runoff compared to 59.5% for those with more than one vessel.
  • Target Lesion Revascularization (CD-TLR): Freedom from clinically-driven revascularization at three years was 65.1% for single-vessel runoff versus 67.2% for multi-vessel runoff.
  • Major Adverse Limb Events (MALE): The proportion of patients remaining MALE-free at three years was 59.9% for single-vessel runoff and 65.2% for multi-vessel runoff.

These statistics indicate that PTAB can be a safe and effective alternative even for the most complex patients who were previously considered poor candidates for endovascular intervention.

How the DETOUR System Redefines Revascularization

Unlike traditional angioplasty or stenting, which attempt to clear a blocked artery, the DETOUR System creates an entirely new pathway for blood. By placing stents through the femoral vein, the system establishes a percutaneous, endovascular femoropopliteal bypass.

This approach allows blood to bypass the diseased SFA segment entirely, improving circulation to the leg while avoiding the inpatient costs and periprocedural morbidity associated with open surgery. For patients experiencing debilitating leg pain, cramping, or numbness, this represents a significant leap in quality of life.

“Findings from this study present that patients with single-vessel runoff maintained excellent patency through three years and can safely benefit from this minimally invasive treatment. These results give operators greater confidence to adopt this technology and treat complex patients who might otherwise be referred for open surgical bypass or have limited treatment options.”
— Sameh Sayfo, MD, MBA, FSCAI, Interventional Cardiologist at Baylor Scott & White The Heart Hospital

Pro Tip: If you or a loved one are discussing PAD treatment options, inquire your vascular specialist about “transmural bypass” options. Understanding whether your condition is categorized as TASC C or D can help determine if a minimally invasive bypass is a viable alternative to open surgery.

Future Trends: The Next Frontier in Endovascular Care

As PTAB becomes more integrated into standard care, the focus is shifting toward optimizing long-term success and expanding real-world application. Industry experts are looking toward several key areas of development:

Real-World Evidence and Diverse Patient Profiles

While clinical trials like DETOUR2 provide a controlled baseline, future trends point toward larger, real-world analyses. This will help clinicians understand how PTAB performs across broader, more diverse patient populations with varying comorbidities.

Refining Anticoagulation Protocols

A critical area of ongoing research is the post-procedure anticoagulation regimen. Researchers are currently evaluating whether specific medication protocols can further improve patency rates and reduce the demand for future revascularization.

Reducing Surgical Dependency

The long-term trend is a clear move toward “surgical avoidance.” By proving that complex patients—even those with limited distal runoff—can benefit from PTAB, the medical community is reducing the reliance on invasive open therapies, thereby lowering hospital stay durations and recovery times.

Frequently Asked Questions

What is PTAB?

Percutaneous Transmural Arterial Bypass (PTAB) is a minimally invasive procedure that creates a new blood flow pathway to bypass blocked arteries in the leg, using a system of stents placed via the femoral vein.

What is PTAB?
System Bypass Percutaneous Transmural Arterial Bypass

How does PTAB differ from a traditional surgical bypass?

A traditional bypass requires open surgery to graft a vein or synthetic tube around a blockage. PTAB is endovascular, meaning it is performed through small incisions using catheters, which typically reduces recovery time and surgical risk.

What does “single-vessel runoff” indicate?

Runoff refers to the arteries that carry blood from the main leg arteries down into the foot. Single-vessel runoff means only one of the three primary arteries is open, which historically made the leg harder to treat via minimally invasive means.

Is the DETOUR System available everywhere?

The DETOUR System is currently approved for use within the United States.

Aim for to stay updated on the latest breakthroughs in vascular health and medtech? Subscribe to our newsletter or leave a comment below to share your thoughts on the future of minimally invasive surgery.

April 23, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New research calls for improved pediatric burn care infrastructure nationwide

by Chief Editor April 21, 2026
written by Chief Editor

The Critical Gap in Pediatric Burn Care

The landscape of burn treatment in the United States is currently an uneven network. While many acute care hospitals provide basic burn services, there is a significant shortage of specialized facilities equipped to handle the unique needs of children.

According to a review paper co-authored by Dr. James C. Jeng, a trauma, burn, and critical care surgeon at UCI Health, the disparity in resources and skill levels across the country creates a precarious situation for pediatric patients.

Currently, fewer than 40 of the 75 American Burn Association (ABA)-verified programs are specifically verified for pediatrics. This gap suggests a future trend where the medical community must prioritize the expansion of pediatric-verified centers to ensure that children receive age-specific, family-centered care.

Did you recognize? Children account for more than 1 in 4 burn cases at the UCI Health Regional Burn Center, highlighting the constant demand for specialized pediatric intervention.

Preparing for the Unthinkable: Mass Casualty Events

Experts are warning that the U.S. Healthcare system is not currently prepared for a mass disaster involving multiple burn casualties. The urgency to reform the burn care network is being driven by several global threats, including climate change and the potential for nuclear or biological disasters.

Preparing for the Unthinkable: Mass Casualty Events
Health Burn Care

To address these vulnerabilities, specialists have convened children’s burn initiatives aimed at improving the understanding of where specialist care is delivered and defining gaps within the emergency care system.

The future of burn care will likely involve a more strategic, coordinated plan of action to ensure that when large-scale events occur, the network can distribute patients to centers with the appropriate resources and expertise without delay.

The Role of Academic Health Systems

Integration with academic health systems is becoming a cornerstone of advanced burn treatment. Facilities like the UCI Health Regional Burn Center—the first of its kind in Orange County—combine clinical care with innovative research.

Exciting New Research on Keto for Pediatric Mental Health

This synergy allows surgeons and researchers to develop new protocols that improve long-term quality of life for patients, moving beyond simple survival toward full functional recovery.

Why “Children Are Not Small Adults”

One of the most critical shifts in burn care is the recognition that pediatric patients require an entirely different approach than adults. As Dr. Syed F. Saquib, Medical Director of the UCI Health Regional Burn Center, notes, burns affect a child’s growth, development, and long-term quality of life in ways they do not affect adults.

Because of these physiological differences, the trend is moving toward highly specialized pediatric burn units that can provide 24-hour complex care tailored to a child’s developing body.

Pro Tip: To prevent the most common pediatric burns, keep hot liquids, soups, and drinks well away from the reach of children, as scalds are the leading cause of injury.

Understanding the Primary Causes of Pediatric Burns

Data from UCI Health reveals a clear pattern in how children are injured, providing a roadmap for future prevention efforts:

View this post on Instagram about Health, Burn
From Instagram — related to Health, Burn
  • Scalds (67%): Caused by hot liquids, bathwater, or drinks.
  • Contact (22%): Resulting from hot surfaces, tools, or appliances.
  • Flame (6%): Caused by open flames or fires.

These statistics underscore the demand for targeted public health campaigns focusing on home safety to reduce the incidence of scalds and contact burns.

Expert Insight: The Importance of Board-Certified Care

The complexity of burn recovery requires a multidisciplinary approach. Surgeons like Dr. James C. Jeng, who is board-certified in both General Surgery and Surgical Critical Care, bring specialized training in shock, trauma, and burn research to the table.

With over 40 years of experience, Dr. Jeng’s function as a professor in the Division of Trauma, Burns, and Surgical Critical Care at the UC Irvine School of Medicine emphasizes the importance of continuing education and fellowship-trained expertise in managing the most complex burn cases.

For more detailed clinical insights, you can explore the research published in The Annals of Surgery Open.

Frequently Asked Questions

What is an ABA-verified burn center?
It’s a facility that has met rigorous standards set by the American Burn Association to provide high-quality, specialized burn care. Some are further verified specifically for pediatric patients.

Why are pediatric burns different from adult burns?
Children’s skin and bodies are developing; burns can impact their growth and long-term development, requiring age-specific and family-centered care.

What is the most common cause of burns in children?
Scalds from hot liquids, bathwater, or drinks are the most common, accounting for approximately 67% of pediatric burn cases at UCI Health.

Join the Conversation

How can we better prepare our communities for burn emergencies? Do you think there is enough awareness regarding pediatric burn prevention?

Share your thoughts in the comments below or subscribe to our newsletter for more health insights!

April 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Microbes in the digestive tract help tailor treatment for melanoma patients

by Chief Editor April 20, 2026
written by Chief Editor

The New Frontier of Oncology: Can Your Gut Bacteria Predict Cancer’s Return?

For decades, the fight against melanoma has relied on a standard playbook: surgical removal followed by immunotherapy to prime the immune system. But for 25% to 40% of patients, the cancer finds a way back. The medical community has long struggled with a frustrating question: Why do some patients thrive although others relapse despite receiving the same treatment?

The answer may not be in the tumor itself, but in the trillions of microbes living in our digestive tracts. Recent breakthroughs from researchers at NYU Langone Health suggest that our gut microbiome acts as a biological “forecast,” predicting the likelihood of cancer recurrence with staggering accuracy—up to 94% in some cases.

Did you know? Your gut contains more microbial cells than you have human cells in your entire body. This “forgotten organ” essentially trains your immune system to distinguish between a harmless piece of food and a dangerous pathogen.

Beyond Geography: The Rise of Microbial “Fingerprinting”

One of the biggest hurdles in microbiome research has been the “geography gap.” For years, a bacterial marker that predicted success in a patient in New York might be completely irrelevant for a patient in Sydney. This inconsistency made it nearly impossible to create a universal diagnostic tool.

View this post on Instagram about Instead, Beyond Geography
From Instagram — related to Instead, Beyond Geography

The game-changer is a new approach called microbial fingerprinting. Instead of looking for one specific “magic” bacterium, scientists are now matching patients based on the overall similarity of their gut ecosystems. By grouping patients with similar “fingerprints,” researchers can predict recurrence regardless of where the patient lives.

This shift moves us away from “one-size-fits-all” medicine and toward a model of precision oncology. By analyzing taxa such as Eubacterium and Clostridium, doctors can now identify high-risk patients before they even initiate their first round of immunotherapy.

The Future Trend: Real-Time Microbiome Monitoring

While current research focuses on a single pre-treatment test, the next logical step is longitudinal monitoring. Imagine a world where a simple stool sample every three months allows oncologists to notice if a patient’s microbiome is shifting toward a “high-risk” state, triggering a change in medication before a tumor even appears on a scan.

From Prediction to Prevention: Engineering the Gut

Predicting recurrence is a massive leap forward, but the ultimate goal is modulation. If we know that certain bacterial groups increase the risk of melanoma returning, can we simply “edit” the gut to remove them or add beneficial ones?

We are already seeing the emergence of several potential therapeutic avenues:

  • Next-Gen Probiotics: Moving beyond yogurt to pharmaceutical-grade bacterial strains designed to enhance the efficacy of drugs like nivolumab and ipilimumab.
  • Fecal Microbiota Transplants (FMT): Transferring “healthy” microbiomes from patients who responded well to immunotherapy into those who didn’t.
  • Precision Nutrition: Using AI-driven diets to starve cancer-fueling bacteria while feeding the ones that support T-cell activity.
Pro Tip: While clinical microbiome transplants are for medical use, you can support your own “immune-training” bacteria by consuming a diverse range of prebiotic fibers—found in garlic, onions, leeks and asparagus—which feed the beneficial taxa in your gut.

Scaling the Model: Other Cancers in the Crosshairs

The implications of the NYU Langone study extend far beyond skin cancer. The gut-immune axis is a universal biological system. Experts believe this “fingerprinting” method will soon be applied to other high-risk malignancies, including:

Colorectal Cancer: Where the microbiome is already known to play a direct role in tumor initiation.

Lung Cancer: Investigating how the “gut-lung axis” influences the success of checkpoint inhibitors.

Breast Cancer: Exploring the role of systemic inflammation driven by gut dysbiosis.

By building global databases of microbial fingerprints, the medical community is essentially creating a “Google Maps” for the human microbiome, allowing doctors to navigate a patient’s unique biological terrain to locate the most effective treatment path.

Case Study: The Impact of Personalized Immunotherapy

Consider a hypothetical patient, “Patient X,” who has high-risk melanoma. Under the old system, they receive standard immunotherapy and wait a year for a scan. Under the new paradigm, a pre-treatment microbiome test reveals a “high-risk fingerprint.” Instead of the standard dose, their doctor combines immunotherapy with a targeted prebiotic regimen to shift their microbiome, potentially turning a predicted relapse into a permanent remission.

Frequently Asked Questions

Q: Does this signify I can prevent cancer by taking probiotics?
A: Not exactly. While a healthy gut supports the immune system, these specific findings are about predicting and enhancing the effectiveness of medical treatments like immunotherapy, not replacing them.

Q: How accurate is the microbiome in predicting cancer recurrence?
A: In recent studies using the fingerprinting method, accuracy ranged from 83% to 94%, depending on the geographical region and the similarity of the microbial groups.

Q: Why does geography affect my gut bacteria?
A: Your microbiome is shaped by your diet, environment, local water sources, and genetics—all of which vary significantly between, for example, North America and Eastern Europe.

Q: Is this test available at my local clinic?
A: Most of these findings are currently in the clinical trial and research phase. However, the goal is to integrate these tests into standard oncology care in the coming years.

Join the Conversation

Do you suppose the future of medicine lies in our microbes? Are you interested in how precision nutrition can impact long-term health? Let us know your thoughts in the comments below or subscribe to our newsletter for the latest breakthroughs in oncology and biotechnology.

Subscribe for More Insights

April 20, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Liver cancer burden rising globally amid shift to metabolic risks

by Chief Editor April 15, 2026
written by Chief Editor

The Looming Liver Cancer Crisis: A Global Shift in Risk Factors

Liver cancer remains a significant global health threat, ranking as the third leading cause of cancer-related deaths worldwide. In 2022 alone, nearly 870,000 new cases were reported, with hepatocellular carcinoma accounting for almost 80% of these. A concerning trend is emerging: even as progress has been made in combating virus-related liver cancer, a new driver is accelerating the disease’s spread – metabolic dysfunction-associated steatotic liver disease (MASLD), linked to obesity, diabetes, and poor lifestyle choices.

China at the Epicenter of the Global Burden

China bears a disproportionate share of the global liver cancer burden, accounting for over 40% of cases. This reflects a complex interplay of historical factors, including widespread hepatitis B and C infections, and increasingly, the rise of metabolic risk factors. Researchers, led by Professor Jian Zhou and Dr. Ao Huang at Fudan University’s Liver Cancer Institute, along with collaborators at Massachusetts General Hospital and Harvard Medical School, have conducted a comprehensive analysis of global cancer databases to understand these evolving trends.

View this post on Instagram about Liver, Cancer
From Instagram — related to Liver, Cancer

A Projected Surge in Cases: The Impact of MASLD

Despite slight declines in age-standardized incidence and mortality rates in recent decades, the absolute number of liver cancer cases is projected to rise dramatically. If current trends continue, over 1.5 million cases could occur annually by 2050. This increase is largely attributed to the growing prevalence of MASLD. While hepatitis B vaccination and antiviral therapies have reduced virus-related liver cancer, metabolic risk factors are rapidly becoming dominant.

Understanding MASLD: A Silent Epidemic

MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a condition where fat accumulates in the liver in individuals who drink little or no alcohol. It’s strongly associated with obesity, type 2 diabetes, and metabolic syndrome. As these conditions become more prevalent globally, so too does the risk of MASLD progressing to more serious liver diseases, including cirrhosis and liver cancer.

Understanding MASLD: A Silent Epidemic
Liver Cancer Global

Disparities in Access to Care: A Global Inequality

The burden of liver cancer is not evenly distributed. Higher incidence and mortality rates are concentrated in low- and middle-income regions, where access to vaccination, screening, and treatment is limited. Men, older adults, and socioeconomically disadvantaged populations are also at higher risk. Environmental factors, such as aflatoxin contamination in food, further exacerbate the problem in certain regions.

Prevention is Key: A 60% Preventability Rate

The research highlights a crucial message: up to 60% of liver cancer cases are preventable. Strategies include vaccination against hepatitis B, lifestyle modifications to address obesity and diabetes, improved food safety to minimize aflatoxin exposure, and early disease management. Public health campaigns promoting healthier diets, increased physical activity, and routine screening for high-risk individuals are essential.

Liver Cancer prevalence rising at astounding rates. Early detection is critical! #cancer #HCC

Pro Tip:

Regular check-ups with your doctor, especially if you have risk factors like obesity, diabetes, or a family history of liver disease, can help detect early signs of liver problems.

The Role of Artificial Intelligence in Transforming Liver Cancer Management

Looking ahead, the integration of artificial intelligence (AI) holds immense promise for transforming liver cancer management. AI can enable personalized risk prediction, earlier diagnosis, and more effective treatment planning. What we have is particularly crucial in resource-limited settings where early detection remains a significant challenge.

The Role of Artificial Intelligence in Transforming Liver Cancer Management
Liver Cancer Global

The Future of Liver Cancer Care: A Collaborative Approach

Addressing the liver cancer crisis requires a coordinated global effort involving public health, oncology, data science, and policy sectors. Integrated strategies that tackle both infectious and metabolic health challenges are essential, particularly in rapidly developing regions. Such collaborations could lead to earlier diagnoses, improved survival rates, and reduced healthcare costs.

Frequently Asked Questions (FAQ)

Q: What is the main cause of liver cancer?
A: While hepatitis B and C were historically major causes, metabolic dysfunction-associated steatotic liver disease (MASLD) is now a leading driver.

Q: Is liver cancer preventable?
A: Yes, up to 60% of cases are preventable through vaccination, lifestyle changes, and early detection.

Q: What are the symptoms of liver cancer?
A: Symptoms can be vague and often appear in later stages, including abdominal pain, weight loss, and jaundice. Early detection through screening is crucial.

Q: How is AI being used in liver cancer diagnosis?
A: AI is being developed to analyze medical images and data to identify early signs of liver cancer and predict individual risk.

Q: Where can I find more information about liver cancer?
A: You can find more information at The National Cancer Institute.

What are your thoughts on the rising rates of liver cancer? Share your comments below and let’s start a conversation about prevention and early detection!

April 15, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Prostate cancer patients recover faster with TULSA than robotic surgery

by Chief Editor April 14, 2026
written by Chief Editor

Minimally Invasive Prostate Cancer Treatment: A New Era of Faster Recovery?

Men diagnosed with localized, intermediate-risk prostate cancer may soon have a new option that prioritizes a quicker return to daily life. A recent randomized clinical trial, presented at the 2026 Society of Interventional Radiology (SIR) Annual Scientific Meeting, suggests that MRI-guided, transurethral ultrasound ablation (TULSA) leads to faster recovery and less short-term disruption compared to traditional robotic prostate surgery.

The CAPTAIN Trial: Key Findings

The CAPTAIN Trial followed 212 men treated at 23 medical centers between 2022, and 2025. Participants were randomly assigned to receive either TULSA or robotic prostatectomy. The results highlighted several key differences in the immediate post-treatment period.

  • Reduced Blood Loss: Men undergoing TULSA experienced significantly less blood loss during the procedure.
  • Shorter Hospital Stays: TULSA patients were typically able to go home the same day, while surgical patients were more likely to require an overnight hospital stay.
  • Faster Recovery: Patients treated with TULSA reported less pain and a quicker return to normal activities within one month of treatment.

“For many patients, how quickly they can get back to work, family life and everyday routines really matters,” explained Dr. David A. Woodrum, the study’s primary investigator. “These early results suggest that TULSA may allow patients to recover more quickly and maintain a better quality of life following treatment, while still effectively treating the cancer.”

TULSA vs. Robotic Prostatectomy: A Closer Gaze

Traditional robotic prostatectomy, while effective at controlling the cancer, can lead to significant long-term side effects, including erectile dysfunction and loss of bladder control. TULSA offers a different approach. It utilizes real-time MRI guidance to deliver high-energy ultrasound through the urethra, precisely heating and destroying cancerous tissue while minimizing damage to surrounding organs.

This precision is a key advantage, potentially preserving urinary and sexual function. The goal is to offer effective cancer treatment with a reduced impact on a patient’s quality of life.

The Rise of Minimally Invasive Prostate Cancer Treatments

The CAPTAIN Trial findings are part of a broader trend toward minimally invasive treatments for prostate cancer. The increasing adoption of techniques like TULSA reflects a growing emphasis on patient-centered care, where recovery time and quality of life are considered alongside cancer control.

View this post on Instagram

Several presentations at the 2026 SIR meeting featured Profound Medical’s TULSA-PRO®, indicating growing interest within the medical community. This technology is also being showcased at other medical meetings, demonstrating its increasing prominence in the field.

Looking Ahead: Long-Term Outcomes and Future Research

While the initial results of the CAPTAIN Trial are promising, researchers are continuing to monitor participants for up to 10 years. This long-term follow-up will provide crucial data on urinary control, sexual function, and the potential need for additional cancer treatment.

The ongoing research aims to provide a comprehensive understanding of TULSA’s effectiveness and durability, helping physicians and patients make informed decisions about the best treatment options.

FAQ

What is TULSA?
TULSA stands for transurethral ultrasound ablation. It’s a minimally invasive procedure that uses ultrasound energy, guided by MRI, to destroy prostate cancer tissue.

Is TULSA right for all prostate cancer patients?
The CAPTAIN Trial focused on men with localized, intermediate-risk prostate cancer. Your doctor will determine if TULSA is an appropriate option based on your individual circumstances.

What are the potential side effects of TULSA?
TULSA generally has fewer immediate side effects than robotic surgery, such as less blood loss and pain. However, like any medical procedure, it carries potential risks, which your doctor will discuss with you.

How does TULSA compare to surgery in terms of cancer control?
Long-term cancer control is still being studied. The CAPTAIN trial is following participants for 10 years to assess this.

Where can I learn more about the CAPTAIN Trial?
Information can be found through the Society of Interventional Radiology.

Did you understand? Minimally invasive procedures are increasingly favored for their ability to reduce recovery times and improve patient quality of life.

Pro Tip: Discuss all treatment options with your doctor and ask questions about the potential benefits and risks of each approach.

Stay informed about the latest advancements in prostate cancer treatment. Explore more articles on our website or subscribe to our newsletter for regular updates.

April 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Targeting senescent fat cells provides new hope for ovarian cancer

by Chief Editor April 13, 2026
written by Chief Editor

Ovarian Cancer Treatment: A New Focus on Fat Cells and the Tumor Microenvironment

Ovarian cancer remains a formidable challenge in women’s health, with a low 5-year survival rate for advanced-stage patients – below 30%. Traditional treatments like surgery, chemotherapy, and targeted therapies often fall short, prompting researchers to explore novel approaches. A recent study is shifting the focus from directly attacking cancer cells to targeting the environment that supports their growth, specifically senescent fat cells.

The Role of Senescent Fat Cells in Ovarian Cancer Metastasis

For years, ovarian cancer research has primarily centered on immune cells within the tumor microenvironment (TME). However, emerging evidence highlights the critical role of adipose tissue – fat tissue – and its derived stem cells (ADSCs) in tumor progression. Researchers have observed that adipose tissue near ovarian tumors often exhibits signs of senescence, a state where cells stop dividing but don’t die, instead releasing harmful inflammatory signals.

View this post on Instagram

This senescence isn’t a random occurrence. Ovarian cancer cells actively induce dysfunction and senescence in ADSCs. This process triggers metabolic abnormalities like glucose intolerance and insulin resistance, creating a “permissive niche” for tumor metastasis. The key messengers in this process are extracellular vesicles (OC-EVs) secreted by the cancer cells, which are rich in the pro-inflammatory cytokine IL-1β.

A Vicious Cycle of Inflammation and Senescence

Once OC-EVs interact with ADSCs, they activate the NF-κB signaling pathway. This activation has a dual effect: it pushes ADSCs into a senescent state and promotes the formation of an inflammasome, leading to the release of more inflammatory factors like IL-1β and IL-18. This creates a dangerous “inflammation-senescence” cycle that continuously remodels the TME, fostering tumor growth and spread.

Analysis of clinical samples confirmed a strong correlation between the degree of adipose tissue senescence and tumor progression. Patients with advanced-stage ovarian cancer showed significantly elevated levels of the senescence marker CDKN2A in their adipose tissue.

Targeting Senescence: Promising Therapeutic Strategies

Based on these findings, researchers explored two targeted therapeutic strategies with remarkable results. The first involved the senolytic combination of dasatinib plus quercetin (DQ). In a mouse model, DQ treatment significantly reduced adipose tissue senescence, lowered reactive oxygen species (ROS) levels, improved glucose metabolism and insulin sensitivity, and substantially decreased the number of tumor metastases.

Targeting Senescence: Promising Therapeutic Strategies

The second strategy utilized resveratrol, a natural antioxidant. Resveratrol acts as an NF-κB pathway inhibitor, suppressing ovarian cancer spheroid formation and reversing the senescent phenotype of ADSCs. It too reduces adipose tissue inflammation by inhibiting the NF-κB and MAPK3 signaling pathways. In vivo experiments showed that resveratrol alleviated metabolic disorders, reduced tumor burden, and lowered the risk of intraperitoneal metastasis.

The research team emphasized a core innovation: “We did not directly target cancer cells themselves, but rather cut off the ‘nutrient supply and metastatic routes’ on which tumors rely by regulating senescent adipocytes in the TME.” This approach contrasts with traditional therapies that can damage normal tissue, potentially leading to senescence and tumor recurrence.

Future Directions and Clinical Translation

Both quercetin and resveratrol are naturally occurring compounds with favorable safety profiles, paving the way for clinical translation. Future research will focus on optimizing administration regimens, exploring combination applications with chemotherapy and immunotherapy, and conducting clinical trials to confirm their efficacy in ovarian cancer patients.

Did you know? Targeting senescent cells isn’t limited to ovarian cancer. This approach is being investigated for a range of age-related diseases and cancers.

FAQ

Q: What is senescence?
A: Senescence is a state where cells stop dividing but don’t die, often releasing inflammatory signals that can harm surrounding tissues.

Q: What are senolytics?
A: Senolytics are drugs that selectively eliminate senescent cells.

Q: What is the tumor microenvironment (TME)?
A: The TME is the complex ecosystem surrounding a tumor, including blood vessels, immune cells, and other supporting cells.

Q: Are quercetin and resveratrol readily available?
A: Yes, both are available as dietary supplements, but it’s important to consult with a healthcare professional before starting any new supplement regimen.

Pro Tip: Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help reduce inflammation and support overall health, potentially impacting the tumor microenvironment.

Want to learn more about cutting-edge cancer research? Explore more articles on News-Medical.net.

April 13, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Study reveals brain mechanisms behind post-stroke urinary incontinence

by Chief Editor April 13, 2026
written by Chief Editor

Unlocking Bladder Control: How Brain Research is Transforming Stroke Recovery

For millions of stroke survivors, regaining independence extends beyond physical mobility. A significant, often overlooked challenge is urinary incontinence, affecting up to 79% of patients immediately following a stroke and persisting in nearly 40% a year later. Now, groundbreaking research from USC’s Keck School of Medicine is shedding light on the neurological basis of this condition, paving the way for targeted therapies and improved quality of life.

The Brain-Bladder Connection: A New Understanding

Traditionally, urinary incontinence after stroke was viewed primarily as a physical issue related to bladder muscle control. However, a recent study published in Stroke reveals a far more complex picture. Researchers utilized functional magnetic resonance imaging (fMRI) to observe brain activity during both voluntary and involuntary bladder contractions. The findings demonstrate that stroke disrupts key brain networks responsible for regulating bladder control, specifically the salience network.

The Brain-Bladder Connection: A New Understanding

“The brain plays a crucial role in regulating the bladder, allowing people to sense bladder fullness and giving them the ability to delay urination,” explains Dr. Evgeniy Kreydin, lead author of the study and adjunct assistant professor of clinical urology at the Keck School of Medicine. “In contrast, stroke survivors often struggle to suppress unwanted bladder contractions and may even lose bladder sensation entirely. The precise neurological foundations of this dysfunction have remained poorly understood until recently.”

What the fMRI Reveals: Voluntary vs. Involuntary Control

The USC team’s innovative approach involved repeated bladder filling and voiding although participants were inside an MRI scanner. This allowed them to differentiate between voluntary and involuntary bladder emptying, revealing striking differences in brain activity. During voluntary urination, both healthy individuals and stroke survivors exhibited activation in brain regions associated with sensorimotor control and executive decision-making. However, involuntary bladder emptying in stroke survivors showed minimal cortical activation.

Perhaps the most significant finding was the inactivity of the salience network during bladder filling preceding involuntary urination in stroke survivors. This network is responsible for evaluating the importance of internal stimuli – like a full bladder – and coordinating the brain’s response. Its failure to engage appears to be a core mechanism underlying post-stroke urinary incontinence.

Pro Tip:

Maintaining hydration is crucial for overall health, but stroke survivors experiencing incontinence should operate with their healthcare provider to determine the optimal fluid intake to manage symptoms effectively.

Future Therapies: Restoring the Brain-Bladder Pathway

These discoveries open exciting possibilities for new interventions. Researchers are exploring several potential therapeutic approaches:

  • Non-invasive Brain Stimulation: Techniques like transcranial magnetic stimulation (TMS) and direct current stimulation (tDCS) could be used to target and reactivate the salience network.
  • Pharmacological Interventions: Developing medications that enhance neural activation in critical continence control regions.
  • Cognitive Training & Biofeedback: Therapies designed to improve bladder awareness and voluntary control.

Dr. Charles Liu, director of the USC Neurorestoration Center and senior author of the study, emphasizes the require for continued research. “The neurological basis of urination is still poorly understood, and additional research will be crucial for the neurorestoration of the urinary and reproductive systems,” he states. “This work not only deepens our understanding of a common post-stroke complication but too provides hope for a better quality of life for millions of stroke survivors globally.”

FAQ: Post-Stroke Incontinence

Q: Is urinary incontinence a common problem after stroke?
A: Yes, it affects a significant number of stroke survivors – up to 79% initially, and nearly 40% one year later.

Q: What part of the brain is involved in bladder control?
A: The salience network, along with regions involved in sensorimotor control and executive decision-making, play crucial roles.

Q: Are there any non-surgical treatments for post-stroke incontinence?
A: Research is exploring brain stimulation techniques, medications, and cognitive/biofeedback therapies.

Did you know?

Urinary incontinence can significantly impact a stroke survivor’s social life and mental well-being. Seeking assist from a healthcare professional is essential.

This research, funded by a grant from the Urology Care Foundation, represents a major step forward in understanding and treating a debilitating condition. As our understanding of the brain-bladder connection deepens, the prospect of restoring bladder control and improving the lives of stroke survivors becomes increasingly realistic.

Learn more about stroke recovery and support resources at The American Stroke Association.

Have you or a loved one experienced urinary incontinence after a stroke? Share your story and questions in the comments below!

April 13, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Mount Sinai launches Adams Valve Institute for advanced heart care

by Chief Editor April 7, 2026
written by Chief Editor

Mount Sinai’s Adams Valve Institute: Pioneering a New Era in Heart Valve Care

The Mount Sinai Health System has launched the Adams Valve Institute, a dedicated center focused on transforming the treatment of heart valve disease. This initiative builds upon decades of groundbreaking work led by Dr. David H. Adams, Chair of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, and aims to address a significant, often underdiagnosed, health challenge impacting millions.

The Scope of the Problem: Why Specialized Valve Care Matters

Heart valve disease affects an estimated 8 to 11 million Americans, contributing to nearly 30,000 deaths annually. These valves are crucial for regulating blood flow, and when diseased, can lead to heart failure and cardiac arrest. Disparities in diagnosis and treatment exist, with African American, Hispanic, and Asian populations, as well as women, facing increased risks of delayed diagnosis and poorer outcomes.

View this post on Instagram

A Focus on Reconstruction and Innovation

The Institute’s core philosophy centers on reconstructive surgical techniques, particularly restoring a patient’s own valve whenever possible. Dr. Adams is internationally recognized for revolutionizing these strategies. This approach contrasts with valve replacement, which often necessitates lifelong blood thinners. The Institute will expand the largest Ross procedure program in the United States, overseen by Dr. Ismail El-Hamamsy, the Institute’s inaugural Director. The Ross procedure replaces a diseased aortic valve with the patient’s pulmonary valve, potentially restoring life expectancy to normal levels and eliminating the demand for blood thinners.

Centers of Excellence: Addressing Complex Needs

The Adams Valve Institute will establish specialized Centers of Excellence to tackle the most challenging areas of valvular heart disease. Mount Sinai’s existing Mitral Valve Repair Reference Center, a world leader in mitral valve management, will serve as a model. New centers will focus on aortic valve disease and the Ross procedure, Marfan syndrome and other connective tissue disorders, arrhythmic mitral valve prolapse, radiation-induced heart disease, adult congenital heart disease, and complex reoperative valve surgery.

Beyond the Operating Room: Research, Education, and Advocacy

The Institute’s impact extends beyond clinical care. It will prioritize multidisciplinary research, supported by infrastructure investments and dedicated faculty. A key component is the creation of a comprehensive digital library of valve reconstructive technique videos, freely accessible to surgeons globally, fostering knowledge sharing and improved standards of care. The Institute will actively advocate for policy reforms to improve access to high-quality surgical care, including standardizing physician licensing and improving payer policies.

Beyond the Operating Room: Research, Education, and Advocacy

Did you realize? The Ross procedure is particularly beneficial for younger patients, offering a long-term solution that avoids the limitations of artificial valve replacements.

The Future of Valvular Heart Disease Treatment

The launch of the Adams Valve Institute signals a shift towards more specialized, reconstructive approaches to heart valve disease. This focus on preserving the patient’s own valve, combined with advanced research and global collaboration, promises to improve outcomes and quality of life for millions. The Institute’s commitment to addressing disparities in care is also crucial, ensuring equitable access to life-saving treatments.

FAQ

What is the Ross procedure? The Ross procedure replaces a diseased aortic valve with the patient’s own pulmonary valve.

Why is valve reconstruction preferred over replacement? Reconstruction often avoids the need for lifelong blood thinners, a common requirement with artificial valve replacements.

Who benefits most from the Adams Valve Institute? Patients with complex or rare valvular heart disease, as well as those from underserved populations, will benefit from the Institute’s specialized expertise and advocacy efforts.

Pro Tip: Early diagnosis is crucial for effective treatment of heart valve disease. If you experience symptoms like shortness of breath, fatigue, or chest pain, consult a cardiologist.

Learn more about heart valve disease and the innovative treatments offered at Mount Sinai. Visit the Mount Sinai Health System website to explore resources and connect with a specialist.

April 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Breast reduction surgery is linked to lower diabetes and heart risk

by Chief Editor March 24, 2026
written by Chief Editor

Beyond Aesthetics: Could Breast Reduction Be a Metabolic Game Changer?

For decades, breast reduction surgery has been recognized for its ability to alleviate physical discomfort and improve quality of life. But emerging research suggests this procedure may offer benefits that extend far beyond the cosmetic – potentially impacting long-term metabolic health. A recent study analyzing data from over 23,000 women indicates a link between breast reduction and a reduced risk of conditions like type 2 diabetes and hypertension.

The Unexpected Connection: Macromastia and Metabolic Risk

Traditionally, breast reduction surgery has addressed issues like chronic back, neck, and shoulder pain, skin irritation, and limitations in physical activity. Patients often report significant improvements in self-esteem and body image following the procedure. Though, the potential for systemic metabolic effects is a relatively new area of investigation. Previous research on fat removal procedures, such as liposuction, has hinted at metabolic improvements, but the impact of breast tissue reduction remained less clear.

Study Highlights: Lower Risks Across the Board

The study, currently available on the SSRN preprint server, categorized patients by body mass index (BMI) to assess the impact of surgery. Researchers found that women who underwent breast reduction experienced notable reductions in several metabolic risk factors. Specifically, in the BMI 25-30 group, surgery was associated with lower rates of diabetes, low HDL cholesterol, elevated blood pressure, and metabolic syndrome. Similar benefits were observed in the BMI 30-35 group, though the reduction in diabetes risk wasn’t statistically significant in this cohort.

Interestingly, the benefits appeared most pronounced in normal-weight and overweight patients. This suggests that the metabolic impact of breast reduction may be influenced by a patient’s baseline weight and overall health status.

How Might This Perform? Unpacking the Potential Mechanisms

Even as the study establishes an association, it doesn’t definitively prove causation. Several theories attempt to explain the observed metabolic benefits. Reducing the weight of breast tissue could alleviate chronic inflammation, a known contributor to insulin resistance and cardiovascular disease. Improved physical activity levels post-surgery may play a role in enhancing metabolic function. The removal of hormonally active breast tissue is another potential factor, though further research is needed to explore this connection.

Diabetes and Heart Health: A Closer Look at the Data

The study revealed that after accounting for various factors, women who had breast reduction surgery had a lower prevalence of type 2 diabetes, hypertension, and disorders of lipoprotein metabolism compared to those who did not. For example, in the BMI 30-35 group, the prevalence of hypertension was 12.36% in the surgery group versus 4.94% in the control group before propensity score matching. These findings align with recent research linking breast reduction surgery to lower diabetes and heart risk.

Important Considerations and Future Research

Researchers acknowledge that residual confounding and differences in healthcare access could contribute to the observed associations. The study also excluded patients with a history of breast cancer or those who had undergone other body contouring procedures, limiting the generalizability of the findings. Further research, including randomized controlled trials, is needed to confirm these results and elucidate the underlying mechanisms.

Did you understand? The American Society of Plastic Surgeons guidelines already emphasize the need for more evidence regarding glycemic control in patients with diabetes undergoing breast reduction surgery.

FAQ

Q: Does breast reduction surgery guarantee I won’t develop diabetes or heart disease?
A: No, it doesn’t guarantee prevention, but the study suggests it may lower your risk.

Q: Is this benefit seen in all patients?
A: The benefits appear more pronounced in normal-weight and overweight individuals.

Q: What further research is needed?
A: Randomized controlled trials are needed to confirm these findings and understand the mechanisms involved.

Pro Tip: Discuss your individual risk factors and potential benefits with a qualified healthcare professional before considering breast reduction surgery.

Want to learn more about the impact of surgery on overall health? Explore our articles on metabolic syndrome and the link between inflammation and chronic disease.

Have questions about breast reduction surgery or its potential health benefits? Share your thoughts in the comments below!

March 24, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Russian Strike on Dnipro Leaves Six Dead and Dozens Injured

    June 29, 2026
  • Germany: 6 Dead in Shooting at Stade Youth Center; 3 Arrested

    June 29, 2026
  • Jan Thomas and Harlem Alexander to Marry in Barcelona

    June 29, 2026
  • Green to Enter Free Agency; Harden Seeks Long-Term Deal

    June 29, 2026
  • PS6 to Showcase the Unique Vision of PlayStation

    June 29, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World